13 results
Pre-Op Nutrition in IBD - IBD Algorithm

Dr. Wade Billings @wabillin

#PreOp #Preoperative #Nutrition #IBDAlgorithm #IBD #Algorithm #gastroenterology
Pre-Op Nutrition ... in IBD - IBD Algorithm ... Preoperative #Nutrition #IBDAlgorithm ... #IBD #Algorithm ... gastroenterology #management
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... fatigue despite clinical ... NRH & Heme eval. re ... ileal Crohn's/resection ... #management
Orofacial Granulomatosis - Diagnosis and Management Algorithm
Idiopathic OFG: isolated swelling of the lips, BX+ non-caseating granuloma
Melkersson-Rosenthal
Diagnosis and Management ... , Sarcoidosis, TB ... Mouthwash • Lidocaine pre-meals ... oral manif. of IBD ... Resolve w Rx of IBD
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Diagnosis and Management ... extrapulmonary cases Clinical ... PE: - Local ... excisional biopsy - Detection ... #Diagnosis #Management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... or those with clinical ... #SSTIs #Algorithm ... #Management #skin
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
Ulcerative Colitis - Management ... Algorithm Curcumin ... Nissle • VSL#3: ↑ clinical ... #Colitis #UC #Management ... #treatment #IBD
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... disease who are ... following drugs are ... Tuberculosis #MDRTB #management ... pharmacology #dosing #idsa
Clinical Algorithm for Emergency Department Evaluation and Management of UTI in Febrile Infants and Young Children

Urinary
Clinical Algorithm ... Evaluation and Management ... of Pediatrics Section ... do not replace clinical ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... Langerhans giant cells are ... characteristic features Clinical ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... Langerhans giant cells are ... characteristic features Clinical ... #Diagnosis #Management